Pasar al contenido principal

PROTEINAS DE INTERACCION CON RNA IMPLICADAS EN EL CONTROL POST-TRANSCRIPCIONAL DE LA EXPRESION GENICA

BFU2017-84492-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Combined ELONA-(RT)qPCR Approach for Characterizing DNA and RNA Aptamers Selected against PCBP-2

  • Moreno, Miguel
  • Fernández-Algar, María
  • Fernández-Chamorro, Javier
  • Ramajo, Jorge
  • Martínez-Salas, Encarnación
  • Briones, Carlos
Improvements in Systematic Evolution of Ligands by EXponential enrichment (SELEX) technology and DNA sequencing methods have led to the identification of a large number of active nucleic acid molecules after any aptamer selection experiment. As a result, the search for the fittest aptamers has become a laborious and time-consuming task. Herein, we present an optimized approach for the label-free characterization of DNA and RNA aptamers in parallel. The developed method consists in an Enzyme-Linked OligoNucleotide Assay (ELONA) coupled to either real-time quantitative PCR (qPCR, for DNA aptamers) or reverse transcription qPCR (RTqPCR, for RNA aptamers), which allows the detection of aptamer-target interactions in the high femtomolar range. We have applied this methodology to the affinity analysis of DNA and RNA aptamers selected against the poly(C)-binding protein 2 (PCBP-2). In addition, we have used ELONA-(RT)qPCR to quantify the dissociation constant (<i>Kd</i>) and maximum binding capacity (<i>Bmax</i>) of 16 high affinity DNA and RNA aptamers. The <i>Kd</i> values of the high affinity DNA aptamers were compared to those derived from colorimetric ELONA performed in parallel. Additionally, Electrophoretic Mobility Shift Assays (EMSA) were used to confirm the binding of representative PCBP-2-specific RNA aptamers in solution. We propose this ELONA-(RT)qPCR approach as a general strategy for aptamer characterization, with a broad applicability in biotechnology and biomedicine., This work was supported by the Spanish Ministerio de Economía y Competitividad (MINECO: grants RTC-2014-1986-1 and BIO2016-79618-R—funded by EU under the FEDER programme—to C.B., and BIO2015-72716-EXP and BFU2017-84492-R to E.M.S.) as well as by an institutional grant from Fundación Ramón Areces. CIBERehd is funded by the Instituto de Salud Carlos III (ISCIII), We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The RBS1 domain of Gemin5 is intrinsically unstructured and interacts with RNA through conserved Arg and aromatic residues

  • Embarc-Buh, Azman
  • Francisco-Velilla, Rosario
  • Camero, Sergio
  • Pérez Cañadillas, José Manuel
  • Martínez-Salas, Encarnación
11 pags., 6 figs., 1 tab., Gemin5 is a multifaceted RNA-binding protein that comprises distinct structural domains, including a WD40 and TPR-like for which the X-ray structure is known. In addition, the protein contains a non-canonical RNA-binding domain (RBS1) towards the C-terminus. To understand the RNA binding features of the RBS1 domain, we have characterized its structural characteristics by solution NMR linked to RNA-binding activity. Here we show that a short version of the RBS1 domain that retains the ability to interact with RNA is predominantly unfolded even in the presence of RNA. Furthermore, an exhaustive mutational analysis indicates the presence of an evolutionarily conserved motif enriched in R, S, W, and H residues, necessary to promote RNA-binding via ¿-¿ interactions. The combined results of NMR and RNA-binding on wild-type and mutant proteins highlight the importance of aromatic and arginine residues for RNA recognition by RBS1, revealing that the net charge and the ¿-amino acid density of this region of Gemin5 are key factors for RNA recognition, This work was supported by grants from MINECO (CTQ2018-84371) to JMP-C, BFU2017-84492-R (to EMS), and B2017/BMD-3770 cofinanced by Autonomous Community of Madrid and FEDER funds to EMS and JMP-C.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functional and structural deficiencies of Gemin5 variants associated with neurological disorders

  • Francisco-Velilla, Rosario
  • Embarc-Buh, Azman
  • Caño-Ochoa, Francisco del
  • Abellán, Salvador
  • Vilar, Marçal
  • Alvarez, Sara
  • Fernandez-Jaen, Alberto
  • Kour, Sukhleen
  • Rajan, Deepa S.
  • Pandey, Udai Bhan
  • Ramón-Maiques, Santiago
  • Martínez-Salas, Encarnación
16 páginas, 7 figuras, 1 tabla. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverolet al, 2019) partner repository with the dataset identifier PXD028959 and PXD028959. All data generated or analyzed during this study are included in the manuscript and supporting files., Dysfunction of RNA-binding proteins is often linked to a wide range of human disease, particularly with neurological conditions. Gemin5 is a member of the survival of the motor neurons (SMN) complex, a ribosome-binding protein and a translation reprogramming factor. Recently, pathogenic mutations in Gemin5 have been reported, but the functional consequences of these variants remain elusive. Here, we report functional and structural deficiencies associated with compound heterozygosity variants within the Gemin5 gene found in patients with neurodevelopmental disorders. These clinical variants are located in key domains of Gemin5, the tetratricopeptide repeat (TPR)-like dimerization module and the noncanonical RNA-binding site 1 (RBS1). We show that the TPR-like variants disrupt protein dimerization, whereas the RBS1 variant confers protein instability. All mutants are defective in the interaction with protein networks involved in translation and RNA-driven pathways. Importantly, the TPR-like variants fail to associate with native ribosomes, hampering its involvement in translation control and establishing a functional difference with the wild-type protein. Our study provides insights into the molecular basis of disease associated with malfunction of the Gemin5 protein., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICIN) and Fondo Europeo de Desarrollo Regional (AEI/FEDERUE) grants BFU2017-84492-R, PID2020-115096RB-I00 (to E Martinez-Salas), and RTI2018-098084-B-100 (to S Ramón-Maiques), Comunidad de Madrid (B2017/BMD-3770 to E Martinez-Salas), and an Institutional grant from Fundación Ramón Areces (to E Martinez-Salas)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TPL2 kinase expression is regulated by the p38γ/p38δ-dependent association of aconitase-1 with TPL2 mRNA

  • Escós, Alejandra
  • Martín Gómez, José Javier
  • González-Romero, Diego
  • Díaz-Mora, Ester
  • Francisco-Velilla, Rosario
  • Santiago, César
  • Cuezva, José M.
  • Domínguez-Zorita, Sonia
  • Martínez-Salas, Encarnación
  • Sonenberg, Nahum
  • Sanz-Ezquerro, Juan José
  • Mehdi Jafarnejad, Seyed
  • Cuenda, Ana
p38γ and p38δ (p38γ/p38δ) regulate inflammation, in part by controlling tumor progression locus 2 (TPL2) expression in myeloid cells. Here, we demonstrate that TPL2 protein levels are dramatically reduced in p38γ/p38δ-deficient (p38γ/δ−/−) cells and tissues without affecting TPL2 messenger ribonucleic acid (mRNA) expression. We show that p38γ/p38δ posttranscriptionally regulates the TPL2 amount at two different levels. p38γ/p38δ interacts with the TPL2/A20 Binding Inhibitor of NF-κB2 (ABIN2)/Nuclear Factor κB1p105 (NF-κB1p105) complex, increasing TPL2 protein stability. Additionally, p38γ/p38δ regulates TPL2 mRNA translation by modulating the repressor function of TPL2 3′ Untranslated region (UTR) mediated by its association with aconitase-1 (ACO1). ACO1 overexpression in wild-type cells increases the translational repression induced by TPL2 3′UTR and severely decreases TPL2 protein levels. p38δ binds to ACO1, and p38δ expression in p38γ/δ−/− cells fully restores TPL2 protein to wild-type levels by reducing the translational repression of TPL2 mRNA. This study reveals a unique mechanism of posttranscriptional regulation of TPL2 expression, which given its central role in innate immune response, likely has great relevance in physiopathology., This research was funded by Ministerio de Ciencia e Innovación (MCIN) Formacion de Personal Investigador (FPI) fellowship BFU2017-84492-R (to A.E., D.G.-R. and E.M.-S.), Ministerio de Educación y Formación Profesional (MEFP) Formacion de Profesorado Universitario (FPU) fellowships (to J.M.-G. and E.D.-M.), an MCIN-Residencia de Estudiantes fellowship (to J.M.-G.), and Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación: MCIN/AEI/10.13039/501100011033 Grants PID2019-108349RB-100 (to J.J.S.-E. and A.C.) and SAF2016-79792R (to J.J.S.-E. and A.C.)., Peer reviewed